Skip to content
thispeptide

Aurelius Health Group

Aurelius advertises physician review, monthly check-ins and messaging around compounded microdose GLP-1 treatment. The care process is described more clearly than the evidence for its specific lower-dose outcomes.

Review by Leah Garner, clinical-evidence editor · Updated October 2026

The short version

Monthly physician contact is a useful commitment to clarify before enrollment. The main caution is the gap between broad microdose claims and evidence on the actual preparation. Confirm the formulation, route and dispenser rather than treating the comparison graphics as an individual forecast.

Disclosure: This Peptide is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.

Aurelius Health, Inc. operates the Aurelius Health Group telehealth platform. It promotes compounded GLP-1 protocols for metabolic and wellness goals, including tirzepatide-based discussion and NAD+ or other combination ingredients. The website presents a subscription with physician review and continuing contact. The business is distinct from the independent medical groups and pharmacies described in its terms. The current public material does not clearly map the advertised subscription to one exact compounded preparation and route. A vial image or a question mentioning capsules does not settle that prescription.

What Aurelius Health Group prescribes, by goal

Weight

  • TirzepatideFDA-approved

    Listed by the seller; no price we hold.

    The homepage discusses microdose tirzepatide and presents an outcome calculator alongside branded-drug dose comparisons. It acknowledges limited large-scale randomized evidence at subtherapeutic doses. Data from a higher studied dose should not be treated as proof of the calculator’s lower-dose prediction.

    Who prescribes

    A licensed clinician

    The clinical network named in the terms and consent is OpenLoop Healthcare Partners, PC and affiliates. Aurelius itself does not provide medical services. The homepage advertises board-certified MD or DO review, while the general consent describes a broader range of licensed professionals. Ask who will actually evaluate and manage the intended protocol. The terms name RedRock Pharmacy, Health Warehouse, Precision Compounding Pharmacy and Triad Rx as partners. That list does not assign every patient to a particular dispenser or establish that every listed pharmacy supplies every preparation.

    The public process begins with a health questionnaire and a physician’s review of history, medications and previous GLP-1 use. The advertised review target is under twenty-four hours, rather than a guaranteed emergency response. A written plan and titration schedule are described after assessment. Monthly physician check-ins and unlimited secure messaging with the care team are included. The consent permits video, telephone and asynchronous care, without making one live format mandatory for every order. Confirm how monthly appointments are arranged and whether a message is handled by the prescribing clinician or another team member.

    Are labs required?

    Not mentioned

    The consent allows third-party diagnostic testing when required and describes separate billing for outside services. The homepage does not establish a universal baseline panel or a complete included test price. Ask which results are needed before prescribing and what will be monitored later. A protocol described as personalized to biology does not itself prove that every relevant biomarker is measured.

    Ready to start with Aurelius Health Group?

    Prices and plans are set on the seller's own site.

    What it claims, and what it cites

    The homepage compares side effects, muscle preservation and treatment persistence across broadly defined full-dose and microdose approaches. It also mixes a low-dose calculator with results from different studied doses. These are not results from an Aurelius-specific randomized trial. The page acknowledges important evidence limits, which should accompany the stronger promotional claims. One listed pharmacy, Triad Rx, received a historical FDA warning; FDA closed that case in 2023 and noted that sterile production had ceased then. This does not establish a current patient assignment or prove that an Aurelius prescription is affected. Confirm the actual dispenser and present preparation.

    Other products and treatment claims

    Unspecified combination ingredients and general longevity claims
    The exact preparation and indication need confirmation; general marketing does not establish a separately priced treatment.

    How it bills

    The subscription separates a first-month promotion from a higher regular monthly charge and describes clinical consultations, the protocol and monitoring. The cancellation policy requires seventy-two hours of notice before renewal. A late request can leave the next cycle charged. Its initial refund window also requires that no subscription service has been received. Laboratory costs, exact drug preparation and any separate delivery charge need confirmation before payment. The advertised program amount is not treated as a verified route-specific medication price.

    For and against

    • For: Clinical network disclosed
    • For: Monthly physician check-ins described
    • For: Written treatment plan advertised
    • For: Pharmacy partners named
    • Against: Actual route and preparation unresolved
    • Against: Microdose graphics exceed direct trial evidence
    • Against: Assigned clinician needs confirmation
    • Against: Partner list does not assign a dispenser

    The evidence behind what it sells

    Right for

    Someone prepared to examine the evidence for a proposed lower-dose protocol and verify the clinician, formulation and monthly follow-up.

    Look elsewhere if

    Someone seeking a proven low-dose outcome, an exact public prescription or a calculator that predicts individual results.

    Other sellers for weight

    Aurelius Health Group

    Frequently asked questions

    Does the calculator predict an individual result?
    No. The site labels its estimates as population-level and acknowledges limited large randomized evidence at subtherapeutic doses. Confirm the evidence for the actual proposed preparation.
    Is Aurelius the treating medical practice?
    Its terms distinguish the platform from OpenLoop Healthcare Partners and affiliated medical groups. The assigned clinician and practice should be confirmed for the selected treatment.
    Does the Triad FDA record establish a current unsafe prescription?
    No. The historical case has a 2023 closeout, and neither document identifies an Aurelius patient. The current pharmacy assignment and preparation still need verification.

    Sources

    See what Aurelius Health Group prescribes today

    Aurelius Health Group sets its own prices, plans and the states it serves. Check them before you start.

    Written by Leah Garner from Aurelius Health Group’s own public pages, against the published methodology. No outcome is claimed first-hand and no score is given. A partnership never changes what this page says; see how the site is paid.